Michael E. Engel

3.1k total citations · 1 hit paper
65 papers, 2.5k citations indexed

About

Michael E. Engel is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Michael E. Engel has authored 65 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Physiology, 26 papers in Pulmonary and Respiratory Medicine and 15 papers in Molecular Biology. Recurrent topics in Michael E. Engel's work include Asthma and respiratory diseases (35 papers), Inhalation and Respiratory Drug Delivery (20 papers) and Respiratory and Cough-Related Research (14 papers). Michael E. Engel is often cited by papers focused on Asthma and respiratory diseases (35 papers), Inhalation and Respiratory Drug Delivery (20 papers) and Respiratory and Cough-Related Research (14 papers). Michael E. Engel collaborates with scholars based in United States, Germany and Netherlands. Michael E. Engel's co-authors include Harold L. Moses, Maureen A. McDonnell, Brian K. Law, Mayshan Ghiassi, Neil A. Bhowmick, Andrei V. Bakin, Carlos L. Arteaga, Christopher A. Lundquist, Mary Aakre and Petra Moroni-Zentgraf and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Michael E. Engel

64 papers receiving 2.4k citations

Hit Papers

Transforming Growth Factor-β1 Mediates Epithelial to Mese... 2001 2026 2009 2017 2001 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Engel United States 20 1.4k 779 698 565 220 65 2.5k
Mark C. Wilkes United States 20 1.2k 0.8× 651 0.8× 238 0.3× 308 0.5× 112 0.5× 36 2.5k
Loïc Garçon France 20 1.8k 1.3× 398 0.5× 715 1.0× 567 1.0× 47 0.2× 86 4.0k
Katri Koli Finland 27 1.2k 0.8× 730 0.9× 129 0.2× 343 0.6× 193 0.9× 56 2.4k
R. Scott Pearsall United States 25 1.4k 1.0× 376 0.5× 296 0.4× 300 0.5× 47 0.2× 62 2.4k
Yuki Morimoto Japan 25 592 0.4× 695 0.9× 275 0.4× 539 1.0× 153 0.7× 89 2.0k
Christian Kersting Germany 22 790 0.6× 294 0.4× 241 0.3× 440 0.8× 60 0.3× 42 1.6k
P Wülfing Germany 22 773 0.5× 191 0.2× 255 0.4× 576 1.0× 92 0.4× 47 1.7k
Fumiko Itoh Japan 26 2.2k 1.5× 281 0.4× 122 0.2× 559 1.0× 141 0.6× 56 3.0k
Karl‐Ludwig Schaefer Germany 25 988 0.7× 865 1.1× 256 0.4× 577 1.0× 41 0.2× 39 2.2k
Afschin Soleiman Austria 24 986 0.7× 312 0.4× 397 0.6× 1.6k 2.9× 112 0.5× 56 2.9k

Countries citing papers authored by Michael E. Engel

Since Specialization
Citations

This map shows the geographic impact of Michael E. Engel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Engel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Engel more than expected).

Fields of papers citing papers by Michael E. Engel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Engel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Engel. The network helps show where Michael E. Engel may publish in the future.

Co-authorship network of co-authors of Michael E. Engel

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Engel. A scholar is included among the top collaborators of Michael E. Engel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Engel. Michael E. Engel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Vogelberg, Christian, Stanley J. Szefler, Elianne J.L.E. Vrijlandt, et al.. (2019). Tiotropium add-on therapy is safe and reduces seasonal worsening in paediatric asthma patients. European Respiratory Journal. 53(6). 1801824–1801824. 13 indexed citations
3.
Szefler, Stanley J., Christian Vogelberg, Jonathan A. Bernstein, et al.. (2019). Tiotropium Is Efficacious in 6- to 17-Year-Olds with Asthma, Independent of T2 Phenotype. The Journal of Allergy and Clinical Immunology In Practice. 7(7). 2286–2295.e4. 26 indexed citations
4.
Vogelberg, Christian, Michael E. Engel, Jonathan A. Bernstein, et al.. (2018). Tiotropium add-on therapy improves lung function in children with symptomatic moderate asthma. The Journal of Allergy and Clinical Immunology In Practice. 6(6). 2160–2162.e9. 32 indexed citations
5.
Andrade, Daniel, Jason Singer, Luke Maese, et al.. (2016). SUMOylation Regulates Growth Factor Independence 1 in Transcriptional Control and Hematopoiesis. Molecular and Cellular Biology. 36(10). 1438–1450. 15 indexed citations
6.
Smock, Kristi J., Joshua D. Schiffman, Mark Fluchel, et al.. (2015). Pegasparaginase treatment alters thrombin generation by modulating the protein C and S system in acute lymphoblastic leukaemia/lymphoma. Blood Coagulation & Fibrinolysis. 26(7). 840–843. 7 indexed citations
7.
Vogelberg, Christian, Michael E. Engel, Petra Moroni-Zentgraf, et al.. (2014). Once-Daily Tiotropium Respimat Add-On to Medium-Dose ICS Is an Efficacious 24-Hour Bronchodilator in Adolescent Patients With Symptomatic Asthma. CHEST Journal. 146(4). 698A–698A. 1 indexed citations
8.
Kerstjens, Huib A.M., Eugene R. Bleecker, Eli O. Meltzer, et al.. (2013). Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety. European Respiratory Journal. 42(Suppl 57). 4629–4629. 4 indexed citations
9.
Corren, Jonathan, Anthony J. Frew, Michael E. Engel, et al.. (2013). Tiotropium as Add-On Therapy to ICS+LABA in Patients With Symptomatic Severe Asthma: Spirometric Assessment Over 24 Hours. CHEST Journal. 144(4). 91A–91A. 5 indexed citations
10.
Tashkin, Donald P., Petra Moroni-Zentgraf, Michael E. Engel, Hendrik Schmidt, & Huib A.M. Kerstjens. (2013). Once-Daily Tiotropium Reduces Risk of Exacerbations and Asthma Worsening in Patients With Symptomatic Asthma Despite Treatment With Inhaled Corticosteroids and Long-Acting β2-Agonists. CHEST Journal. 144(4). 90A–90A. 3 indexed citations
11.
Kerstjens, Huib A.M., Eugene R. Bleecker, Eli O. Meltzer, et al.. (2013). Tiotropium as add-on to inhaled corticosteroids significantly improves asthma control as reflected by the ACQ responder rate. European Respiratory Journal. 42(Suppl 57). P4130–P4130. 5 indexed citations
12.
Doherty, Dennis E., Donald P. Tashkin, Tim Harrison, et al.. (2013). Improvements in Lung Function With Tiotropium as Add-On Controller Therapy to ICS+LABA for Patients With Symptomatic Severe Asthma. CHEST Journal. 144(4). 88A–88A. 3 indexed citations
13.
Barrett, Caitlyn W., J. Joshua Smith, Nicholas O. Markham, et al.. (2012). Kaiso Directs the Transcriptional Corepressor MTG16 to the Kaiso Binding Site in Target Promoters. PLoS ONE. 7(12). e51205–e51205. 20 indexed citations
14.
Kerstjens, Huib A.M., Bernd Disse, Theo A. Bantje, et al.. (2011). Tiotropium improves lung function in patients with severe uncontrolled asthma: A randomized controlled trial. Journal of Allergy and Clinical Immunology. 128(2). 308–314. 211 indexed citations
15.
Fischer, Melissa A., et al.. (2011). Mtg16/Eto2 Contributes to Murine T-Cell Development. Molecular and Cellular Biology. 31(13). 2544–2551. 22 indexed citations
16.
Engel, Michael E. & Scott W. Hiebert. (2009). Proleukemic RUNX1 and CBFβ Mutations in the Pathogenesis of Acute Leukemia. Cancer treatment and research. 145. 127–147. 7 indexed citations
17.
Frangoul, Haydar, et al.. (2007). Acyclovir‐resistant herpes simplex virus pneumonia post‐unrelated stem cell transplantation: A word of caution. Pediatric Transplantation. 11(8). 942–944. 17 indexed citations
18.
Engel, Michael E., Pran K. Datta, & Harold L. Moses. (1998). Signal transduction by transforming growth factor-β: A cooperative paradigm with extensive negative regulation. Journal of Cellular Biochemistry. 72(S30-31). 111–122. 51 indexed citations
19.
Engel, Michael E., Pran K. Datta, & Harold L. Moses. (1998). RhoB Is Stabilized by Transforming Growth Factor β and Antagonizes Transcriptional Activation. Journal of Biological Chemistry. 273(16). 9921–9926. 87 indexed citations
20.
Kawabata, Masahiro, Takeshi Imamura, Kohei Miyazono, Michael E. Engel, & Harold L. Moses. (1995). Interaction of the Transforming Growth Factor-β Type I Receptor with Farnesyl-protein Transferase-α. Journal of Biological Chemistry. 270(50). 29628–29631. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026